Bioactive composites for bone regeneration. Review;Bioaktywne kompozyty w regeneracji kości. Przeglad

Ortopedia Traumatologia Rehabilitacja

Volumn 10, Issue 3, 2008, Pages 201-210

  Włodarski, Krzysztof H ^a   Włodarski, Paweł K ^a   Galus, Ryszard ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Biocomposites; Bone regeneration; Ceramics

Indexed keywords

2 HYDROXYACID; ALKALINE PHOSPHATASE BONE ISOENZYME; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; COBALT; COLLAGEN; COLLAGEN TYPE 1; COPOLYMER; FILLER; HYDROXYAPATITE; IRON; NICKEL; OSTEOCALCIN; POLYCARBONATE; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIC ACID; POLYMER; TITANIUM; TUNGSTEN;

BIODEGRADABLE IMPLANT; BONE ALLOGRAFT; BONE CONDUCTION; BONE GRAFT; BONE MARROW; BONE MINERAL; BONE MINERALIZATION; BONE REGENERATION; CELL DIFFERENTIATION; CERAMICS; COLLAGEN SYNTHESIS; COMPOSITE GRAFT; HISTOGENESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; OSTEOCYTE; PROTEIN EXPRESSION; REVIEW; BONE DEVELOPMENT; BONE DISEASE; BONE PROSTHESIS; INSTRUMENTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; PATHOPHYSIOLOGY; PLASTIC SURGERY; TISSUE ENGINEERING; TISSUE REGENERATION;

BONE DISEASES; BONE REGENERATION; BONE SUBSTITUTES; CERAMICS; GUIDED TISSUE REGENERATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOGENESIS; RECONSTRUCTIVE SURGICAL PROCEDURES; TISSUE ENGINEERING;

EID: 54049153225     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Hutmacher DW, Cool S. Concepts of scaffold-based tissue engineering - the rationale to use solid free-form fabrication techniques. J Cell Mol Med 2007; 11(4): 654-69.
2. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 1991; 2(3): 187-208.
3. Santos-Ruiz L, Mowatt DJ, Marguerie A, Tukiainen D, Kellomäki M, Törmälä P, Suokas E, Arstila H, Ashammakhi N, Ferretti P. Potential use of craniosynostotic osteoprogenitors and bioactive scaffolds for bone engineering. J Tissue Eng Regen Med 2007; 1(3): 199-210.
4. Lee SJ, Lim GJ, Lee JW, Atala A, Yoo JJ. In vitro evaluation of a poly(lactide-co-glycolide)-collagen composite scaffold for bone regeneration. Biomaterials 2006; 27(18): 3466-72.
5. Kang SW, Yang HS, Seo SW, Han DK, Kim BS. Apatite-coated poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for bone tissue engineering. J Biomed Mater Res A 2007; Sep 26 [Epub ahead of print]. Dostepny pod adresem URL: http://www3.interscience.wiley.com/ cgi-bin/abstract/116324233/ABSTRACT
6. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997; 36(1): 17-28.
7. Hollinger JO, Leong K. Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials 1996; 17(2): 187-94.
8. Miller AC, Mog S, McKinney L, Luo L, Allen J, Xu J, Page N. Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects. Carcinogenesis 2001; 22(1): 115-25.
9. Du C, Schneider GB, Zaharias R, Abbott C, Seabold D, Stanford C, Moradian-Oldak J. Apatite/amelogenin coating on titanium promotes osteogenic gene expression. J Dent Res 2005; 84(11): 1070-4.
10. Chen F, Feng X, Wu W, Ouyang H, Gao Z, Cheng X, Hou R, Mao T. Segmental bone tissue engineering by seeding osteoblast precursor cells into titanium mesh-coral composite scaffolds. Int J Oral Maxillofac Surg 2007; 36(9): 822-7.
11. Lefaix H, Asselin A, Vermaut P, Sautier JM, Berdal A, Portier R, Prima F. On the biocompatibility of a novel Ti-based amorphous composite: structural characterization and in-vitro osteoblasts response. J Mater Sci Mater Med 2007; Oct 4 [Epub ahead of print]. Dostepny pod adresem URL: http://www.springerlink.com/content/17q6592727661284
12. Locci P, Becchetti E, Pugliese M, Rossi L, Belcastro S, Calvitti M, Pietrarelli G, Staffolani N. Phenotype expression of human bone cells cultured on implant substrates. Cell Biochem Funct 1997; 15(3): 163-70.
13. Gronowicz G, McCarthy MB. Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 1996; 14(6): 878-87.
14. Yao J, Cs-Szabó G, Jacobs JJ, Kuettner KE, Glant TT. Suppression of osteoblast function by titanium particles. J Bone Joint Surg Am 1997; 79(1): 107-12.
15. Hou LT, Liu CM, Liu BY, Chang PC, Chen MH, Ho MH, Jehng SM, Liu HC. Tissue engineering bone formation in novel recombinant human bone morphogenic protein 2-atelocollagen composite scaffolds. J Periodontol 2007; 78(2): 335-43.
16. Lee JY, Kim KH, Shin SY, Rhyu IC, Lee YM, Park YJ, Chung CP, Lee SJ. Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules. J Biomed Mater Res A 2006; 76(3): 530-9.
17. Arpornmaeklong P, Suwatwirote N, Pripatnanont P, Oungbho K. Growth and differentiation of mouse osteoblasts on chitosan-collagen sponges. Int J Oral Maxillofac Surg 2007; 36(4): 328-37.
18. Price RL, Waid MC, Haberstroh KM, Webster TJ. Selective bone cell adhesion on formulations containing carbon nanofibers. Biomaterials 2003; 24(11): 1877-87.
19. Supronowicz PR, Ajayan PM, Ullmann KR, Arulanandam BP, Metzger DW, Bizios R. Novel current-conducting composite substrates for exposing osteoblasts to alternating current stimulation. J Biomed Mater Res 2002; 59(3): 499-506.
20. Pettis GY, Kaban LB, Glowacki J. Tissue response to composite ceramic hydroxyapatite/demineralized bone implants. J Oral Maxillofac Surg 1990; 48(10): 1068-74.
21. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 1996; 17(1): 31-5.
22. Wlodarski PK, Haberko K, Haberko M, Pyda A, Włodarski KH. Implantation of natural hydroxyapatite from porcine bone into soft tissues in mice. Folia biologica (Kraków) 2005; 53: 183-7.
23. Yang Z, Yuan H, Tong W, Zou P, Chen W, Zhang X. Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals. Biomaterials 1996; 17(22): 2131-7.
24. Shikinami Y, Okazaki K, Saito M, Okuno M, Hasegawa S, Tamura J, Fujibayashi S, Nakamura T. Bioactive and bioresorbable cellular cubic-composite scaffolds for use in bone reconstruction. J R Soc Interface. 2006; 3(11): 805-21.
25. Nordström E, Ohgushi H, Yoshikawa T, Yokobori AT Jr, Yokobori I. Osteogenic differentiation of cultured marrow stromal stem cells on surface of microporous hydroxyapatite based mica composite and macroporous synthetic hydroxyapatite. Biomed Mater Eng 1999; 9(1): 21-6.
26. Yoshikawa T, Ohgushi H, Dohi Y, Davies JE. Viable bone formation in porous hydroxyapatite: marrow cell-derived in vitro bone on the surface of ceramics. Biomed Mater Eng 1997; 7(1): 49-58.
27. Tsuang YH, Lin FH, Sun JS, Hang YS, Liu HC. In vitro cell behavior of osteoblasts on Pyrost bone substitute. Anat Rec 1997; 247(2): 164-9.
28. Nguyen H, Qian JJ, Bhatnagar RS, Li S. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem Biophys Res Commun 2003; 311(1): 179-86.
29. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells. Biomaterials 2008; 29(7): 790-6.
30. Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials 2007; 28(35): 5291-7.
31. Dong J, Uemura T, Kikuchi M, Tanaka J, Tateishi T. Long-term durability of porous hydroxyapatite with low-pressure system to support osteogenesis of mesenchymal stem cells. Biomed Mater Eng 2002; 12(2): 203-9.
32. Okumura M, Ohgushi H, Dohi Y, Katuda T, Tamai S, Koerten HK, Tabata S. Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res 1997; 37(1): 122-9.
33. Vuola J, Göransson H, Böhling T, Asko-Seljavaara S. Bone marrow induced osteogenesis in hydroxyapatite and calcium carbonate implants. Biomaterials 1996; 17(18): 1761-6.
34. Muschler GF, Nitto H, Matsukura Y, Boehm C, Valdevit A, Kambic H, Davros W, Powell K, Easley K. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 2003; 407: 102-18.
35. Noshi T, Yoshikawa T, Dohi Y, Ikeuchi M, Horiuchi K, Ichijima K, Sugimura M, Yonemasu K, Ohgushi H. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/ hydroxyapatite composites. Artif Organs 2001; 25(3): 201-8.
36. Noshi T, Yoshikawa T, Ikeuchi M, Dohi Y, Ohgushi H, Horiuchi K, Sugimura M, Ichijima K, Yonemasu K. Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J Biomed Mater Res 2000; 52(4): 621-30.
37. Dong J, Kojima H, Uemura T, Kikuchi M, Tateishi T, Tanaka J. In vivo evaluation of a novel porous hydroxyapatite to sustain osteogenesis of transplanted bone marrow-derived osteoblastic cells. J Biomed Mater Res 2001; 57(2): 208-16.
38. Dennis JE, Haynesworth SE, Young RG, Caplan AI. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1992; 1(1): 23-32.
39. Gu WW, Xu YH, Cao HQ, Zhang BD, Lu KB. In vivo osteogenic properties of the composite of periosteal-derived osteoblast and collagen-coated true bone ceramics. Di Yi Jun Yi Da Xue Xue Bao 2002; 22(6): 518-20.
40. Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J. Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials 2001; 22(13): 1705-11.
41. Jeong SI, Ko EK, Yum J, Jung CH, Lee YM, Shin H. Nanofibrous Poly(lactic acid)/Hydroxyapatite Composite Scaffolds for Guided Tissue Regeneration. Macromol Biosci 2007 Dec 28. 1[Epub ahead of print]. Dostepny pod adresem URL: http://www3.interscience.wiley.com/cgi-bin/abstract/ 117874117/ABSTRACT
42. Ma PX, Zhang R, Xiao G, Franceschi R. Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 2001; 54(2): 284-93.
43. Tsigkou O, Hench LL, Boccaccini AR, Polak JM, Stevens MM. Enhanced differentiation and mineralization of human fetal osteoblasts on PDLLA containing Bioglass composite films in the absence of osteogenic supplements. J Biomed Mater Res A 2007; 80(4): 837-51.
44. Yang XB, Webb D, Blaker J, Boccaccini AR, Maquet V, Cooper C, Oreffo RO. Evaluation of human bone marrow stromal cell growth on biodegradable polymer/bioglass composites. Biochem Biophys Res Commun 2006; 342(4): 1098-107.
45. Moursi AM, Winnard AV, Winnard PL, Lannutti JJ, Seghi RR. Enhanced osteoblast response to a polymethylmethacrylate-hydroxyapatite composite. Biomaterials 2002; 23(1): 133-44.
46. Zhang Y, Tanner KE, Gurav N, Di Silvio L. In vitro osteoblastic response to 30 vol% hydroxyapatite-polyethylene composite. J Biomed Mater Res A 2007; 81(2): 409-17.
47. Di Silvio L, Dalby MJ, Bonfield W. Osteoblast behaviour on HA/PE composite surfaces with different HA volumes. Biomaterials 2002; 23(1): 101-7.
48. Zhao F, Yin Y, Lu WW, Leong JC, Zhang W, Zhang J, Zhang M, Yao K. Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds. Biomaterials 2002; 23(15): 3227-34.
49. Attawia MA, Herbert KM, Laurencin CT. Osteoblast-like cell adherence and migration through 3-dimensional porous polymer matrices. Biochem Biophys Res Commun 1995; 213(2): 639-44.
50. Elgendy HM, Norman ME, Keaton AR, Laurencin CT. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material. Biomaterials 1993; 14(4): 263-9.
51. Cool SM, Kenny B, Wu A, Nurcombe V, Trau M, Cassady AI, Grondahl L. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) composite biomaterials for bone tissue regeneration: in vitro performance assessed by osteoblast proliferation, osteoclast adhesion and resorption, and macrophage proinflammatory response. J Biomed Mater Res A 2007; 82(3): 599-610.
52. Toquet J, Rohanizadeh R, Guicheux J, Couillaud S, Passuti N, Daculsi G, Heymann D. Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic. J Biomed Mater Res 1999; 44(1): 98-108.
53. Peter SJ, Lu L, Kim DJ, Mikos AG. Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials 2000; 21(12): 1207-13.
54. Rai B, Teoh SH, Ho KH, Hutmacher DW, Cao T, Chen F, Yacob K. The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 2004; 25(24): 5499-506.
55. Goshima J, Goldberg VM, Caplan AI. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop Relat Res 1991; 269: 274-83.
56. Murata M, Arisue M, Sato D, Sasaki T, Shibata T, Kuboki Y. Bone induction in subcutaneous tissue in rats by a newly developed DNA-coated atelocollagen and bone morphogenetic protein. Br J Oral Maxillofac Surg 2002; 40(2): 131-5.